← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 11, 2019Last known activity
Sep 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 15 trials)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT06567080CollaboratorPhase 1Sep 30, 2024
- NCT06479356Lead sponsorPhase 2Aug 15, 2024
- NCT06414135CollaboratorPhase 1Jun 12, 2024
- NCT06297408Lead sponsorPhase 1Mar 31, 2024
- NCT06170294CollaboratorPhase 1Jan 1, 2024
- NCT06093841Lead sponsorPhase 2Nov 30, 2023
- NCT06149169Lead sponsorPhase 2Aug 17, 2023
- NCT05765006Lead sponsorPhase 1Feb 24, 2023
- NCT05590221CollaboratorPhase 2Dec 10, 2022
- NCT05727683Lead sponsorPhase 1Apr 28, 2022
- NCT06144385Lead sponsorPhase 1Mar 24, 2022
- NCT05259813Lead sponsorPhase 1Feb 28, 2022
- NCT04718883Lead sponsorPhase 2Jan 13, 2021
- NCT04812691Lead sponsorPhase 1Jul 10, 2020
- NCT04089215Lead sponsorPhase 2Jun 11, 2019
Details
- Last known activity
- Sep 30, 2024